Evidence map›Paper›PMID 38534932›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

ITGAV Promotes the Progression of Head and Neck Squamous Cell Carcinoma.

Lingyi Xu, Jeremy G Barrett, Jiayi Peng, Suk Li, Diana Messadi, Shen Hu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Lingyi XuSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
Jeremy G BarrettSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
Jiayi PengSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
Suk LiSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
Diana MessadiSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
Shen HuSchool of Dentistry, University of California, Los Angeles, CA 90095, USA.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Head and neck squamous cell carcinoma (HNSCC) refers to the malignancy of squamous cells in the head and neck region. Ranked as the seventh most common cancer worldwide, HNSCC has a very low survival rate, highlighting the importance of finding therapeutic targets for the disease. Integrins are cell surface receptors that play a crucial role in mediating cellular interactions with the extracellular matrix (ECM). Within this protein family, Integrin αV (ITGAV) has received attention for its important functional role in cancer progression. In this study, we first demonstrated the upregulation of

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsCell Line, TumorHumansIntegrin alphaVSquamous Cell Carcinoma of Head and NeckIntegrin alphaVhead and neck squamous cell carcinomaintegrinintegrin αVSOX11

Identifiers

PMID38534932
PMCPMC10969037
OpenAlexW4392361086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.